Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2002-07-12

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-291X(02)00719-2PMID 12150980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

  2002cited by this paper
• Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.

  2002cited by this paper
• Elevated Akt Activity Protects the Prostate Cancer Cell Line LNCaP from TRAIL-induced Apoptosis*

  2001cited by this paper
• Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo.

  2001cited by this paper
• Pro-survival Function of Akt/Protein Kinase B in Prostate Cancer Cells

  2001cited by this paper
• Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent Pathway*

  2001cited by this paper
• A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

  2001cited by this paper
• Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.

  2001cited by this paper
• Akt and Bcl-xL Promote Growth Factor-independent Survival through Distinct Effects on Mitochondrial Physiology*

  2001cited by this paper
• Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

  2001cited by this paper
• Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

  2000cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.

  2000cited by this paper
• Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

  2000cited by this paper
• Adenoviral-Mediated Transfer of the TNF-Related Apoptosis-Inducing Ligand/Apo-2 Ligand Gene Induces Tumor Cell Apoptosis1

  2000cited by this paper
• The epidermal growth factor receptor and its inhibition in cancer therapy.

  1999cited by this paper
• The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis.

  1999cited by this paper
• Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

  1999cited by this paper
• EGF receptor.

  1999cited by this paper
• Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B.

  1999cited by this paper
• 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• A Caspase-9 Variant Missing the Catalytic Site Is an Endogenous Inhibitor of Apoptosis*

  1999cited by this paper
• Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line

  1998cited by this paper
• EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL

  1998cited by this paper
• Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor.

  1997cited by this paper
• Apoptosis by death factor.

  1997cited by this paper
• The Epidermal Growth Factor Receptor in Breast Cancer

  1997cited by this paper
• ErbB Receptors and EGF-like Ligands: Cell Lineage Determination and Oncogenesis Through Combinatorial Signaling

  1997cited by this paper
• Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family*

  1996cited by this paper
• Epidermal growth factor-related peptides and their receptors in human malignancies.

  1995cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Signal transduction by receptors with tyrosine kinase activity.

  1990cited by this paper
• Growth factor receptor tyrosine kinases.

  1988cited by this paper
• Receptors for epidermal growth factor and other polypeptide mitogens.

  1987cited by this paper

• Chemopreventive effects and anti-tumorigenic mechanisms of Actinidia arguta, known as sarunashi in Japan toward 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)- induced lung tumorigenesis in a/J mouse

  2022cites this paper
• Molecular Mechanisms of Phytochemical Actions in Cancer

  2019cites this paper
• University of Groningen Targeted induction of apoptosis for cancer therapy

  2017cites this paper
• South Asian Medicinal Compounds as Modulators of Resistance to Chemotherapy and Radiotherapy

  2016cites this paper
• Instability restricts signaling of multiple fibroblast growth factors

  2015cites this paper
• Natural Polyphenols Target the Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Signaling Pathway for Cancer Chemoprevention

  2015cites this paper
• Genistein enhances TRAIL-induced cancer cell death via inactivation of autophagic flux.

  2015cites this paper
• The Effects of Amphiregulin Induced MMP-13 Production in Human Osteoarthritis Synovial Fibroblast

  2014influential citation
• Genistein enhances the effect of cisplatin on the inhibition of non-small cell lung cancer A549 cell growth in vitro and in vivo

  2014cites this paper
• Review Article The TRAIL of oncogenes to apoptosis

  2013cites this paper
• The TRAIL of oncogenes to apoptosis

  2013cites this paper
• Phytochemicals As Chemosensitizers: From Molecular Mechanism to Clinical Significance

  2013cites this paper
• Induction of Apoptosis by Combined-treatment with Genistein and TRAIL in U937 Human Leukemia Cells

  2011cites this paper
• Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.

  2011cites this paper
• TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.

  2011cites this paper
• Chinese Anti鄄 Cancer a Ssociation

  2011cites this paper
• Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL

  2011cites this paper
• Inhibition of IGF-1R-Dependent PI3K Activation Sensitizes Colon Cancer Cells Specifically to DR5-Mediated Apoptosis But Not to rhTRAIL

  2010cites this paper
• The ubiquitin ligase Itch mediates the antiapoptotic activity of epidermal growth factor by promoting the ubiquitylation and degradation of the truncated C‐terminal portion of Bid

  2010cites this paper
• Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells?

  2010cites this paper
• TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives.

  2010cites this paper
• Lung cancer therapeutics that target signaling pathways: an update

  2010cites this paper
• Hypoxia protects neuronal cells from human prion protein fragment‐induced apoptosis

  2010cites this paper
• Improving the response to molecular targeting of the TRAIL death receptors in colon cancer cells

  2010cites this paper
• Role of intracellular signalling pathways in conferring resistance to endocrine therapies in breast cancer

  2010cites this paper
• Efficacy of a Triple Treatment with Irradiation, Agonistic TRAIL Receptor Antibodies and EGFR Blockade

  2009cites this paper
• Discovery and Development of an Aurora Kinase Inhibitor Clinical Candidate Using an Image-Based Assay for Measuring Proliferation, Apoptosis, and DNA Content

  2009cites this paper
• Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1.

  2009cites this paper
• The TRAIL to targeted therapy of breast cancer.

  2009cites this paper
• Effektivität von molekular zielgerichteten Dreifach-Kombinationstherapien

  2009cites this paper
• Keratinocyte Growth Factor (KGF) Regulates Estrogen Receptor-α (ER-α) Expression and Cell Apoptosis via Phosphatidylinositol 3-kinase (PI3K)/Akt Pathway in Human Breast Cancer Cells

  2009cites this paper
• Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.

  2009cites this paper
• Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage

  2009cites this paper
• Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1

  2009influential citation
• Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells.

  2009cites this paper
• Anticancer immunotherapy in combination with proapoptotic therapy.

  2008cites this paper
• Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL.

  2008cites this paper
• Epidermal Growth Factor Receptor-Directed Therapy in Esophageal Cancer

  2008cites this paper
• Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice.

  2008cites this paper
• Euphorbiae Immifusae Sensitizes Apoptosis of TRAIL-resistant Human Gastric Adenocarcinoma AGS Cells

  2008cites this paper
• Effects of Exercise Training and Selenium on MCT1 and MCT4 Protein Levels in Skeletal Muscles of Diabetic Goto-Kakizaki Rats

  2008cites this paper
• TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

  2008cites this paper
• Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention.

  2007cites this paper
• Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3.

  2007cites this paper
• The clinical trail of TRAIL.

  2006cites this paper
• Targeted induction of apoptosis for cancer therapy: current progress and prospects.

  2006cites this paper
• Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells.

  2006cites this paper
• Simultaneous Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling and Enhanced Activation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor-mediated Apoptosis Induction by an scFv:sTRAIL Fusion Protein with Specificity for Human EGFR*

  2005cites this paper
• HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: An unexpected effect on TRAIL‐induced apoptosis

  2005cites this paper
• Role of iron in inactivation of epidermal growth factor receptor after asbestos treatment of human lung and pleural target cells.

  2005cites this paper
• Targeting Inducible Chemotherapy Resistance Mechanisms in Colon Cancer

  2005cites this paper
• Integrins as a distinct subtype of dependence receptors

  2005cites this paper
• ZD1839 (Gefitinib, ‘Iressa’), an epidermal growth factor receptor‐tyrosine kinase inhibitor, enhances the anti‐cancer effects of TRAIL in human esophageal squamous cell carcinoma

  2005influential citation
• Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.

  2005cites this paper
• Early Responses to Oxidative Stress In Heart Cells: Signals From The Cell Membrane To The Nucleus and Beyond

  2005cites this paper
• Mechanism of action of a novel "combi-triazene" engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency.

  2005cites this paper
• The death receptor TRAIL in cancer cell apoptosis

  2005cites this paper
• Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.

  2004cites this paper
• Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.

  2004cites this paper
• Suprathreshold excitation of frog tectal neurons by short spike trains of single retinal ganglion cell

  2004cites this paper
• The Combination of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL/Apo2L) and Genistein Is Effective in Inhibiting Pancreatic Cancer Growth

  2004cites this paper
• Role of Iron in the Mechanism of Asbestos-Induced Apoptosis in Human Lung and Pleural Target Cells

  2004influential citation
• Cytotoxic and genotoxic effects of some substituted tetrazolo[1,5-c]quinazolines.

  2004cites this paper
• Antiapoptotic effect of EGF on mouse hepatocytes associated with downregulation of proapoptotic Bid protein.

  2003cites this paper
• APOPTÓZA ZPROST¤EDKOVANÁ DEATH RECEPTORY: ÚLOHA FASL A TRAIL P¤I SMRTI MALIGNÍCH BUNùK DEATH RECEPTORS-MEDIATED APOPTOSIS: ROLE OF FASL AND TRAIL IN CANCER CELLS KILLING

  2003cites this paper
• Overcoming resistance of cancer cells to apoptosis

  2003cites this paper
• Regulation of normal and malignant prostate cell biology by IGF-I: mechanisms and modulation by dietary polyphenols and energy restriction

  2003cites this paper
• Effect of acute hypoxia on ATP-sensitive potassium currents in substantia gelatinosa neurons of juvenile rats

  2003cites this paper